Schedule 13G ownership disclosure
NextCure Inc
Common Stock, $0.001 par value per share · CUSIP: 65343E207
Event date: 2025-10-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 154,021.00 · Class: 5.8%
- Squadron Capital Management LLC
Shares: 173,861.00 · Class: 6.5%
- Matthew Sesterhenn
Shares: 173,861.00 · Class: 6.5%
- William Blank
Shares: 173,861.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-25-000009
- Form type
- SCHEDULE 13G
- Filer
- NextCure, Inc.
- CIK
- CIK 1661059
- Filed
- Oct 24, 2025
- Reporting period
- Oct 21, 2025
- Description
- Schedule 13G beneficial ownership